RT Journal Article
SR Electronic
T1 COVID-19 and Multisystem Inflammatory Syndrome in Latin American children: a multinational study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.29.20184242
DO 10.1101/2020.08.29.20184242
A1 Omar Yassef Antúnez-Montes
A1 Maria Isabel Escamilla
A1 Augusto Flavio Figueroa-Uribe
A1 Erick Arteaga-Menchaca
A1 Manuel Lavariega-Saráchaga
A1 Perla Salcedo-Lozada
A1 Priscilla Melchior
A1 Rodrigo Beréa de Oliveira
A1 Juan Carlos Tirado Caballero
A1 Hernando Pinzon Redondo
A1 Laura Vanessa Montes Fontalvo
A1 Roger Hernandez
A1 Carolina Chavez
A1 Francisco Campos
A1 Fadia Uribe
A1 Olguita del Aguila
A1 Jorge Alberto Rios Aida
A1 Andrea Parra Buitrago
A1 Lina Maria Betancur Londoño
A1 León Felipe Mendoza Vega
A1 Carolina Almeida Hernández
A1 Michela Sali
A1 Julian Esteban Higuita Palacio
A1 Jessica Gomez-Vargas
A1 Adriana Yock-Corrales
A1 Danilo Buonsenso
YR 2020
UL http://medrxiv.org/content/early/2020/09/02/2020.08.29.20184242.abstract
AB Background To date, there are no comprehensive data on pediatric COVID-19 from Latin America. This study aims to assess COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) in Latin American children, in order to appropriately plan and allocate resources to face the pandemic on a local and International leverMethods Ambispective multicentre cohort study from five Latin American countries. Children aged 18 years or younger with microbiologically confirmed SARS-CoV-2 infection were included.Findings 409 children were included, with a median age of 53.0 years (IQR 0.6–9.0). Of these, 95 191 (23.2%) were diagnosed with MIS-C. 191 (46.7%) children were admitted to hospital and 52 (12.7%) required admission to a Pediatric Intensive Care Unite (PICU). 92 (22.5%) patients required oxygen support: 8 (2%) were started on continuous positive airway pressure (CPAP) and 29 (7%) on mechanical ventilation. 35 (8.5%) patients required inotropic support. The following factors were associated with PICU admission: pre-existing medical condition (P < 0.0001), immunodeficiency (P = 0.01), lower respiratory tract infection (P< 0.0001), gastrointestinal symptoms (P = 0.006), radiological changes suggestive of pneumonia and acute respiratory distress syndrome (P< 0.0001), low socioeconomic conditions (P 0.009).Conclusions This study shows a generally more severe form of COVID-19 and a high number of MIS-C in Latin American children, compared with studies from China, Europe and North America, and support current evidence of a more severe disease in Latin/Hyspanic children or in people of lower socioeconomic level. The findings highlight an urgent need of more data of COVID-19 in South America.Competing Interest StatementThe authors have declared no competing interest.Funding StatementnothingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by the CoviDOMINGO core group and approved by the Ethic Committee of the coordinating center and by each participating center (Mexico: COMINVETICA-30072020-CEI0100120160207; Colombia: PE-CEI-FT-06; Peru: N 42-IETSI-ESSALUD-2020; Costa Rica: CEC-HNN-243-2020). The study was conducted in accordance with the Declaration of Helsinki and its amendments. No personal nor identifiable data were collected during the conduct of this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesavailable upon request